Novel multi-omic biosignature for identification of early-stage invasive breast cancer patients who do and do not benefit from adjuvant radiation treatment after breast conservation surgery.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Troy Bremer, Karuna Mittal, Chirag Shah, Frank A. Vicini, Naamit Kurshan Gerber, Melissa Krystel-Whittemore, Clayton C. Yates, Balasubramanyanam Karanam, Walter Bell, Charles E. Cox, Abigail Beard, Geza Acs, Steven Shivers, Mark Mentrikoski, David J. Dabbs, Jess Savala, Pat W. Whitworth, Charlotta Wadsten
Institutions: PreludeDx (United States), Allegheny Health Network, Michigan Healthcare Professionals, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Johns Hopkins University, Tuskegee University, University of South Florida, AdventHealth Tampa, Sundsvall Municipality
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4410811101